Detail akcie Eckert & Ziegler online

Business Summary: Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Eckert & Ziegler SE revenues increased 4% to EUR224.1M. Net income applicable to common stockholders excluding extraordinary items increased 2% to EUR29.9M. Revenues reflect Medical segment increase of 15% to EUR119.7M. Net income was partially offset by Selling expenses increase of 9% to EUR21.6M (expense), Currency gains/losses increase of 63% to EUR2.6M (expense).